Preclinical Imaging Market (By Product: CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents, Services; By End User: Biotech Companies, Pharmaceutical Companies, Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030


The global preclinical imaging market size was exhibited at USD 4.92 billion in 2022 and is expected to surpass around USD 8.35 billion by 2030, growing at a CAGR of 6.82% during the forecast period 2022 to 2030.

  • By product, the optical imaging segment accounted for 14.01% of revenue share in 2021.
  • In 2021, North America contributes the highest share around of 29%.

Preclinical Imaging Market Size 2022 To 2030

The preclinical imaging market is in reference to the living animal vision which helps in analysis. Imaging modes as well as drug development are extremely important for researchers. The number of funds received all various organizations for research purpose have increased in recent years and these are extremely supportive of Preclinical Research. As the market demand for preclinical imaging has also increased in recent years the market will show significant growth.

The existing market players will lead to the introduction of innovative technologies for molecular imaging and it will also receive a large amount of funding from various organizations and this will lead to the growth of the market during the forecast period. Technological advancements will also play a significant role in the growth of the market as it has led to the introduction of hybrid systems for imaging. 

Preclinical Research is extremely important in transforming the performance of modern medicines and how these medicines are delivered in order to treat and resolve the problems that patients face. As clinical research organizations are also increasing in number the market is expected to grow well. There are many other factors that will help the growth of the market like the policies or the rights that protect the animals due to which the use of these animals for testing will be reduced. The availability of alternative methods in the market like that of computer-based models and micro-dosing is growing rapidly.

Report Scope of the Preclinical Imaging Market

Report Coverage Details
Market Size in 2022 USD 4.92 Billion
Market Size by 2030 USD 8.35 Billion
Growth Rate from 2022 to 2030 CAGR of 6.82%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered
  • By Product
  • By End User
Regions Covered
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa


Growth Factors

Most of the market players are engaged in research and development activities in order to enhance the existing products in the market. These companies are also focused on making investments to launch new products. These are the most important strategies adopted by organizations. The number of partnerships, collaborations, and agreements has also increased in recent years which has led to the introduction and enhancement of better technologies. In order to strengthen the product portfolio, the companies are constantly focusing on expanding their presence in various geographical locations.

The government support received by companies in developing nations will play a significant role in the growth of the market. Translational activities of research have also grown. The regulatory policies in Asian countries have evolved and they are extremely beneficial for the growth of the market. The adoption of novel imaging technologies at the molecular level has also grown significantly. The increase in the number of biotechnology companies and pharmaceutical companies across the globe will lead to the growth of the market.

The demand for multi-modality systems has also increased which will drive market growth in the coming years. The demand for non-invasive procedures on small animals has also increased significantly. The number of funds received by the organizations and the initiatives taken by the organizations for the Preclinical Research will propel the market growth. 

  • The number of technological advancements made in the field is high
  • Development in the hybrid imaging system will drive the market growth
  • the way modern medicines are delivered will be revolutionized by preclinical research
  • The revolutionization to health problems and the treatment for health problems will also be revolutionized
  • The need for noninvasive techniques for the imaging of small animals is in greater demand which will we increase the need for research

Key Market Drivers

  • Increase in the number of investments - As there has been a growth in the investments and the funds received for research and development purposes the market is expected to grow well. With the speed at which technological advancements are taking place the market is expected to grow well. The use of imaging systems of the hybrid kind is also driving market growth. Preclinical research has played an important role in transforming modern medicine, especially in the ways how health issues are resolved and treated with the help of modern medicine.
  • Increase in clinical research organizations - Clinical research organizations as well as pharmaceutical companies are making use of the in vivo systems in Preclinical Research. The growing demand for imaging techniques hurdles led to the introduction of more and more organizations conducting the research. This research is conducted with the help of advanced devices, especially in developed regions across the world.

Key Market Challenges

  • Stringent regulations - As the framework provided by the government bodies for the conduction of research is strict the preclinical imaging market will suffer in the long run. There are many limitations with the procedural and technical aspects and this will hamper the growth of the market in the coming years period there are many restrictions imposed on the testing of animals through the activist that fight for animal rights and this will also hamper the growth of the market during the forecast period.
  • High costs - The operational cost for conducting the research is extremely high and the installation of various equipment for conducting the procedures is also expensive and this will hamper the growth of the market during the forecast period.

Key Market Opportunities

  • Increased technological advancements - Lucrative opportunities will be provided in the market as the companies are making use of invoice systems for Preclinical Research. The number of investments made in the market has led to the introduction of hybrid systems. Molecular imaging techniques are also advanced and this will also provide good opportunities for the growth of the market in the long run.
  • Growing demand for imaging techniques - When it comes to small animals the procedures that are noninvasive are in greater demand and the need for these imaging techniques will prove to be a factor that will help in the growth of the market in the coming years. As the demand for veterinary hospitals has also grown significantly the market will continue to grow well in the coming years. In order to meet the needs of the educational institute the market will grow well. The availability of good infrastructure for Advanced Research will boost market growth. The imaging technique of multimodal molecular type will help in enhancing the performance of the doctors by providing better insights on the disease through screening staging, surveillance, therapy guidance, planning guidance, and prognosis. It will also help in efficiently managing the therapy and monitoring the therapy constantly. Due to the use of this type of imaging personalized medicine, targeted therapy and pre-symptomatic detection will all be possible in a short period of time. 

Segments Insight

Product Insights

On the basis of the product, the optical imaging devices segment is expected to have the largest share in the market in the coming years period as a large number of small animals are used in the imaging for the discovery of drugs the market is expected to grow well. The segment of multimodal imaging devices is also expected to show significant growth in the coming years period technological advancements will play a significant role in the growth of the market as it will lead to an introduction of integrated systems like anatomical digital imaging systems and molecular digital imaging systems. these systems help in multiple screenings of a single unit. These are the devices of the new generation that have integrated the technology of imaging and this shall provide maximum growth opportunities in the coming years period the segment of the reagents will also continue to grow in the coming years. Increased digitalization in the field has provided an interface that is user-friendly and it is finding major application in the field of oncology research. 

End-User Insights

On the basis of the end user, biotechnology companies are expected to have the highest share of the market during the forecast period. The amount of research and development work carried out in these companies has grown significantly and the amount of investment made for these activities has also grown. The constant need for advanced drugs will create more demand for research and development work. The use of this technology in biotechnology companies is more due to its application. Research institutes and pharmaceutical companies also make use of preclinical imaging techniques to a great extent. 

Regional Insights

Maximum revenue was generated through the North American region in the past and there are many factors that support the growth of this market in the North American region. The research infrastructure in the North American region is extremely developed which proves to be a major growth factor. The skilled professionals available in the North American region plays a significant role in the growth of the market. The number of preclinical initiatives taken by the organizations or the projects that are in progress or large in number. The use of technologically advanced equipment is more in the North American region due to which quality products can be obtained. A large number of initiatives are taken by the government in various regions of the North American area which are extremely supportive of the development and research activities for all the projects in the region.

Preclinical Imaging Market Share, By Region, 2021 (%)

The research and development activities receive a boost in the nations like Canada especially due to the introduction of the programs like tax credits. as the regulatory guidelines are favorable and the cost of research is less in the Asia Pacific region the market growth will be good. These factors will bring more opportunities in the Asia Pacific region for Preclinical Research. The outsourcing industry in clinical research is also growing in developing nations of the world like India and China.

Key Market Developments

In the year 2022, PerkinElmer, an organization that is committed to innovation for the healthy world announced its expansion of the in vivo system of imaging and it launched Vega imaging systems. It is a hands-free platform and ultrasound platform which makes use of automated technology in order to increase the speed of non-invasive activities for research.

Key Market Players

  • Bruker Corporation (US)
  • MR Solutions (UK)
  • PerkinElmer (US)
  • Fujifilm Holdings Corporation (Japan)
  • Milabs B.V. (The Netherlands)
  • Mediso Ltd. (Hungary)
  • Miltenyi Biotec GmbH (Germany)
  • LI-COR
  • Inc. (US)
  • Aspect Imaging (Israel)
  • Trifoil Imaging (US)

Segments Covered in the Report

(Note*: We offer reports based on sub-segments as well. Kindly, let us know if you are interested)

By Product

  • CT Imaging
  • MRI Imaging
  • PET/SPECT Imaging
  • Multi-modal Imaging
  • Optical Imaging
  • Ultrasound Imaging
  • Photoacoustic Imaging
  • Reagents
  • Services

By End-User

  • Biotech Companies
  • Pharmaceutical Companies 
  • Research Institutes

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the preclinical imaging market size?
The global preclinical imaging market size was accounted at USD 4.92 billion in 2022 and it is expected to reach around USD 8.35 billion by 2030.
What will be the CAGR of global preclinical imaging market?
The global preclinical imaging market is poised to grow at a CAGR of 6.82% from 2022 to 2030.
Who are the prominent players operating in the preclinical imaging market?
The major players operating in the preclinical imaging market are Bruker Corporation (US), MR Solutions (UK), PerkinElmer (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), Miltenyi Biotec GmbH (Germany), LI-COR, Inc. (US), Aspect Imaging (Israel), Trifoil Imaging (US)
Which are the driving factors of the preclinical imaging market?
The driving factors the preclinical imaging market include increase in the number of investments, increase in the clinical research organizations and the growing need for the imaging techniques for the small animals is expected to play a significant role in the growth of the market.
Which region will lead the global preclinical imaging market?
North America region will lead the global preclinical imaging market during the forecast period 2022 to 2030.
  • Report Code:2345
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:November 2022

PROCEED TO BUY

   USD 4900
   USD 6900
   USD 8900

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample